Bausch Health Companies Inc (BHC) Stock Price, News, Quotes-Moomoo

CA Stock MarketDetailed Quotes

BHC Bausch Health Companies Inc

Watchlist

9.570
+0.060+0.63%

15min DelayTrading Sep 17 12:04 ET

3.51BMarket Cap-5422P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Eye Health Supplements Global Outlook & Forecasts 2024-2029 With Amway, Bausch Health Companies, Nature's Bounty, Vitabiotics, and ZeaVision Leading the $3.28 Billion Market - ResearchAndMarkets.com
Businesswire18minutes ago
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Cuts Target Price to $9
Moomoo NewsSep 17 08:34 ET · Ratings
Toronto Stocks Flat; Bausch + Lomb Rises on Report of Possible Sale
WSJSep 16 16:16 ET · Markets
Bausch + Lomb's Stock Soars 14% on Report Company Is Considering Selling Itself
MarketWatchSep 16 10:39 ET
Bausch + Lomb Shares Up in Premarket Amid Sale Consideration
WSJSep 16 09:18 ET
Bausch + Lomb Reportedly Exploring Sale to Handle Bausch Health Spinoff
Seeking AlphaSep 14 08:54 ET

Comments

Moomoo IPO Buzz

Feb 11, 2022 02:15

Columns IPO-pedia | Bausch Health's aesthetics devicemaker Solta files for IPO

Bausch Health Companies said on Febrary 8th that its wholly owned subsidiary, Solta Medical Corp., filed for an initial public offering with the U.S. Securities and Exchange Commission.
It plans to list on the Nasdaq under the symbol SLTA. Morgan Stanley and Goldman Sachs will lead the deal.
Business Overview
Solta Medical is a leading global aesthetic medical device company focused on the development, manufacture and sale ...

Heat List

Overall

No Data